Xie Ya-Ming, Lu Wenfeng, Cheng Jian, Dai Mugen, Liu Si-Yu, Wang Dong-Dong, Fu Tian-Wei, Ye Tai-Wei, Liu Jun-Wei, Zhang Cheng-Wu, Huang Dong-Sheng, Liang Lei
Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, General Surgery, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Navy Medical University), Shanghai, People's Republic of China.
J Hepatocell Carcinoma. 2023 Sep 4;10:1423-1433. doi: 10.2147/JHC.S414789. eCollection 2023.
Nutritional and inflammatory status has been reported to be associated with the prognosis of hepatocellular carcinoma (HCC), but many studies did not include all biomarkers simultaneously. The present study aimed to determine the impact of Naples prognostic score (NPS) on the long-term survival in patients undergoing hepatectomy for HCC.
Patients with HCC after curative resection were eligible. Then, all patients were stratified into three groups according to the NPS. Clinical features and survival outcomes were compared among the three groups. Independent prognostic factors were determined by COX analysis. The time dependent receiver operating characteristic (ROC) curves were used to compare prognostic performance with other immunonutrition scoring systems.
A total of 476 patients were enrolled eventually. Baseline characteristics showed that patients with higher NPS had a higher proportion of poor liver function and advanced tumor features. Accordingly, Kaplan-Meier survival curves showed that patients with higher NPS had a lower rate of overall survival (OS) and recurrence-free survival (RFS). Multivariable COX analysis demonstrated that NPS was an independent risk factor of OS (NPS group 2 vs 1: HR=1.958, 95% CI: 1.038-3.369, p = 0.038; NPS group 3 vs 1: HR=2.608, 95% CI: 1.358-5.008, p=0.004, respectively) and RFS (NPS group 2 vs 1: HR=2.014, 95% CI: 1.299-2-3.124, p=0.002; NPS group 3 vs 1: HR=2.002, 95% CI: 1.262-3.175, p=0.003, respectively). The time-dependent ROC curve showed that NPS was superior to other models in prognostic performance and discriminatory power for long-term survival (median AUC 0.675, 95% CI: 0.586-0.712, P < 0.05).
The NPS is a simple tool strongly associated with long-term survival in patients undergoing curative hepatectomy for HCC.
营养和炎症状态已被报道与肝细胞癌(HCC)的预后相关,但许多研究并未同时纳入所有生物标志物。本研究旨在确定那不勒斯预后评分(NPS)对接受HCC肝切除术患者长期生存的影响。
根治性切除术后的HCC患者符合条件。然后,根据NPS将所有患者分为三组。比较三组患者的临床特征和生存结局。通过COX分析确定独立预后因素。使用时间依赖性受试者工作特征(ROC)曲线将预后性能与其他免疫营养评分系统进行比较。
最终共纳入476例患者。基线特征显示,NPS较高的患者肝功能差和肿瘤特征晚期的比例较高。相应地,Kaplan-Meier生存曲线显示,NPS较高的患者总生存(OS)率和无复发生存(RFS)率较低。多变量COX分析表明,NPS是OS(NPS第2组与第1组:HR = 1.958,95%CI:1.038 - 3.369,p = 0.038;NPS第3组与第1组:HR = 2.608,95%CI:1.358 - 5.008,p = 0.004)和RFS(NPS第2组与第1组:HR = 2.014,95%CI:1.299 - 2 - 3.124,p = 0.002;NPS第3组与第1组:HR = 2.002,95%CI:1.262 - 3.175,p = 0.003)的独立危险因素。时间依赖性ROC曲线显示,NPS在长期生存的预后性能和鉴别能力方面优于其他模型(中位AUC 0.675,95%CI:0.586 - 0.712,P < 0.05)。
NPS是一种与接受HCC根治性肝切除术患者长期生存密切相关的简单工具。